C-KIT MUTATION DETECTION , PCR
c-Kit mutations are associated with shorter survival and higher relapse risk following standard AML therapy in AML Patients. It also confirms diagnosis of Systemic Mastocytosis where patients without the D816V pathogenic variation are sensitive to the tyrosine kinase inhibitor Imatinib mesylate (Imatinib).
Parameter(s) covered : 1
Report Frequency: Sample Wed / Sat by 11 am; Report 9 Working days
Special Instruction: Physician Prescription is mandatory.
Price : ₹ 6700.00
Parameters
- C-KIT MUTATION DETECTION BY PCR